For the year ending 2025-12-31, SBFM has $30,079,167 in assets. $7,040,707 in debts.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 9,123,308 | |||
| Accounts receivable | 3,459,864 | |||
| Inventory | 13,472,025 | |||
| Prepaid expenses | 798,384 | |||
| Total current assets | 26,853,581 | |||
| Property & equipment | 557,370 | |||
| Intangible assets | 1,889,370 | |||
| Deferred tax asset | 0 | |||
| Right-of-use-asset | 778,846 | |||
| Total long-term assets | 3,225,586 | |||
| Total assets | 30,079,167 | |||
| Accounts payable & accrued expenses | 5,664,212 | |||
| Earnout payable | 295,797 | |||
| Income tax payable | 268,276 | |||
| Current portion - right-of-use-liability | 215,637 | |||
| Total current liabilities | 6,443,922 | |||
| Right-of-use-liability | 596,785 | |||
| Total long-term liabilities | 596,785 | |||
| Total liabilities | 7,040,707 | |||
| Preferred stock, series b 0.10 par value per share 1,000,000 shares authorized 130,000 shares issued and outstanding at december 31, 2025 and december 31, 2024, respectively | 13,000 | |||
| Common stock, 0.001 par value per share 3,000,000,000 shares authorized 4,905,945 and 2,580,098 shares issued and outstanding at december 31, 2025 and december 31, 2024, respectively | 4,905 | |||
| Capital paid in excess of par value | 98,100,990 | |||
| Accumulated comprehensive income | -65,309 | |||
| Accumulated (deficit) | -75,015,126 | |||
| Total shareholders' equity | 23,038,460 | |||
| Total liabilities and shareholders' equity | 30,079,167 | |||
Sunshine Biopharma Inc. (SBFM)
Sunshine Biopharma Inc. (SBFM)